B
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
Price:
26.67
INR
1.14%
Market Closed
Market Cap:
₹1.5B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
B
|
Balaxi Pharmaceuticals Ltd
NSE:BALAXI
|
IN |
|
C
|
Cowell e Holdings Inc
HKEX:1415
|
CN |
Income Statement
Earnings Waterfall
Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals Ltd
Income Statement
Balaxi Pharmaceuticals Ltd
Balaxi Pharmaceuticals Ltd
Currency: INR
| Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||||||||||||||||
| Interest Expense |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
3
|
3
|
3
|
5
|
6
|
9
|
13
|
17
|
18
|
18
|
28
|
29
|
36
|
0
|
0
|
|
| Revenue |
136
N/A
|
218
+60%
|
330
+51%
|
399
+21%
|
456
+14%
|
895
+96%
|
1 372
+53%
|
1 901
+39%
|
2 313
+22%
|
2 376
+3%
|
2 475
+4%
|
2 432
-2%
|
2 794
+15%
|
3 038
+9%
|
3 200
+5%
|
3 448
+8%
|
3 364
-2%
|
3 196
-5%
|
2 879
-10%
|
2 621
-9%
|
2 413
-8%
|
2 410
0%
|
2 636
+9%
|
2 761
+5%
|
2 926
+6%
|
2 977
+2%
|
2 765
-7%
|
2 757
0%
|
|
| Gross Profit | |||||||||||||||||||||||||||||
| Cost of Revenue |
(105)
|
(154)
|
(256)
|
(296)
|
(329)
|
(668)
|
(1 020)
|
(1 428)
|
(1 722)
|
(1 744)
|
(1 800)
|
(1 724)
|
(1 956)
|
(2 023)
|
(2 016)
|
(2 123)
|
(2 027)
|
(1 945)
|
(1 732)
|
(1 509)
|
(1 287)
|
(1 265)
|
(1 415)
|
(1 550)
|
(1 657)
|
(1 672)
|
(1 520)
|
(1 499)
|
|
| Gross Profit |
31
N/A
|
50
+61%
|
73
+45%
|
102
+40%
|
128
+25%
|
227
+77%
|
352
+55%
|
472
+34%
|
592
+25%
|
632
+7%
|
675
+7%
|
708
+5%
|
838
+18%
|
1 015
+21%
|
1 184
+17%
|
1 325
+12%
|
1 337
+1%
|
1 251
-6%
|
1 147
-8%
|
1 113
-3%
|
1 126
+1%
|
1 145
+2%
|
1 221
+7%
|
1 211
-1%
|
1 268
+5%
|
1 306
+3%
|
1 245
-5%
|
1 258
+1%
|
|
| Operating Income | |||||||||||||||||||||||||||||
| Operating Expenses |
(15)
|
(32)
|
(36)
|
(48)
|
(45)
|
(86)
|
(115)
|
(145)
|
(171)
|
(183)
|
(190)
|
(207)
|
(341)
|
(496)
|
(658)
|
(782)
|
(790)
|
(754)
|
(694)
|
(679)
|
(679)
|
(688)
|
(737)
|
(841)
|
(914)
|
(1 012)
|
(1 046)
|
(1 068)
|
|
| Selling, General & Administrative |
(9)
|
(13)
|
(16)
|
(17)
|
(45)
|
(36)
|
(53)
|
(93)
|
(168)
|
(113)
|
(143)
|
(160)
|
(297)
|
(490)
|
(651)
|
(775)
|
(658)
|
(735)
|
(671)
|
(653)
|
(544)
|
(665)
|
(742)
|
(830)
|
(610)
|
(993)
|
(1 027)
|
(1 049)
|
|
| Depreciation & Amortization |
0
|
0
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(3)
|
(3)
|
(3)
|
(4)
|
(4)
|
(5)
|
(6)
|
(7)
|
(7)
|
(18)
|
(19)
|
(23)
|
(26)
|
(21)
|
(23)
|
(21)
|
(21)
|
(19)
|
(19)
|
(19)
|
(20)
|
|
| Other Operating Expenses |
(6)
|
(20)
|
(21)
|
(31)
|
(0)
|
(49)
|
(60)
|
(49)
|
(0)
|
(67)
|
(43)
|
(43)
|
(39)
|
0
|
0
|
0
|
(114)
|
0
|
0
|
0
|
(114)
|
0
|
27
|
10
|
(285)
|
0
|
0
|
0
|
|
| Operating Income |
16
N/A
|
32
+98%
|
37
+14%
|
55
+50%
|
83
+51%
|
141
+71%
|
238
+68%
|
328
+38%
|
421
+28%
|
449
+7%
|
486
+8%
|
501
+3%
|
497
-1%
|
519
+5%
|
526
+1%
|
543
+3%
|
548
+1%
|
498
-9%
|
453
-9%
|
434
-4%
|
447
+3%
|
457
+2%
|
484
+6%
|
371
-23%
|
354
-5%
|
294
-17%
|
200
-32%
|
190
-5%
|
|
| Pre-Tax Income | |||||||||||||||||||||||||||||
| Interest Income Expense |
0
|
0
|
0
|
0
|
6
|
0
|
0
|
0
|
20
|
(0)
|
(0)
|
(0)
|
48
|
(3)
|
(3)
|
(3)
|
14
|
13
|
9
|
5
|
(50)
|
(18)
|
(18)
|
(28)
|
(91)
|
(36)
|
(40)
|
(36)
|
|
| Non-Reccuring Items |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(467)
|
(410)
|
(394)
|
(383)
|
84
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(1)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Other Income |
8
|
8
|
17
|
21
|
0
|
38
|
44
|
40
|
2
|
15
|
1
|
(6)
|
0
|
71
|
111
|
69
|
8
|
(35)
|
(74)
|
(29)
|
6
|
(34)
|
(78)
|
(38)
|
24
|
(35)
|
21
|
(18)
|
|
| Pre-Tax Income |
24
N/A
|
40
+64%
|
54
+34%
|
76
+42%
|
89
+16%
|
179
+102%
|
281
+57%
|
368
+31%
|
443
+20%
|
464
+5%
|
486
+5%
|
495
+2%
|
545
+10%
|
587
+8%
|
633
+8%
|
609
-4%
|
569
-7%
|
9
-98%
|
(22)
N/A
|
16
N/A
|
20
+27%
|
488
+2 323%
|
388
-21%
|
306
-21%
|
287
-6%
|
223
-22%
|
181
-19%
|
136
-25%
|
|
| Net Income | |||||||||||||||||||||||||||||
| Tax Provision |
(5)
|
(9)
|
(13)
|
(23)
|
(28)
|
(41)
|
(54)
|
(56)
|
(62)
|
(63)
|
(65)
|
(62)
|
(69)
|
(76)
|
(88)
|
(103)
|
(110)
|
(104)
|
(84)
|
(68)
|
(44)
|
(34)
|
(31)
|
(31)
|
(36)
|
(33)
|
(35)
|
(41)
|
|
| Income from Continuing Operations |
20
|
31
|
41
|
53
|
61
|
138
|
228
|
312
|
381
|
401
|
421
|
433
|
477
|
511
|
545
|
506
|
460
|
(95)
|
(106)
|
(52)
|
(24)
|
455
|
356
|
274
|
251
|
189
|
145
|
94
|
|
| Net Income (Common) |
20
N/A
|
31
+59%
|
41
+29%
|
53
+32%
|
61
+14%
|
138
+126%
|
228
+65%
|
312
+37%
|
381
+22%
|
401
+5%
|
421
+5%
|
433
+3%
|
477
+10%
|
511
+7%
|
545
+7%
|
506
-7%
|
460
-9%
|
(95)
N/A
|
(106)
-11%
|
(52)
+51%
|
(24)
+54%
|
455
N/A
|
356
-22%
|
274
-23%
|
251
-9%
|
189
-25%
|
145
-23%
|
94
-35%
|
|
| EPS (Diluted) |
6.56
N/A
|
10.43
+59%
|
2.36
-77%
|
5.33
+126%
|
6.1
+14%
|
13.77
+126%
|
22.75
+65%
|
31.23
+37%
|
38.14
+22%
|
40.14
+5%
|
42.07
+5%
|
43.3
+3%
|
47.66
+10%
|
51.09
+7%
|
54.53
+7%
|
49.58
-9%
|
9.08
-82%
|
-9.32
N/A
|
-2.06
+78%
|
-1.01
+51%
|
-0.46
+54%
|
1.64
N/A
|
6.47
+295%
|
4.98
-23%
|
4.54
-9%
|
3.42
-25%
|
2.77
-19%
|
1.84
-34%
|
|
Switch to:
Switch to:
See Also
Discover More
